73906 Federal Register / Vol. 79, No. 239 / Friday, December 12, 2014 / Notices 

• The Department of Justice works to 

facilitate communication and build 

relationships between tribes and state, 

local, and private partners in law 

enforcement, public safety, victim 

services, and civil rights, to promote 

prosperous and resilient tribal 

communities, and to use dispute 

resolution techniques such as mediation 

to resolve community conflicts and 

tensions. 

• The Department of Justice 

recognizes the link between healthy, 

prospering families and public safety, 

and the need to coordinate law 

enforcement efforts with educational, 

housing, environmental-protection, and 

public-health services. 

Sustainability 

• The Department of Justice will 

continue taking steps to institutionalize 

its commitment to tribal justice and to 

make its officers and employees aware 

of these Attorney General Guidelines 

stating principles for working with 

federally recognized Indian tribes, so 

that progress in areas important to tribes 

continues regardless of changes in 

Department personnel. 

These guidelines and principles are 

intended to improve the internal 

management of the Department of 

Justice. They are not intended to and do 

not create any right or benefit, 

substantive or procedural, enforceable at 

law or in equity by any party in any 

matter, civil or criminal, against the 

United States, its departments, agencies, 

or entities, its officers, employees, or 

agents, or any other person, nor do these 

guidelines or principles place any 

limitations on otherwise lawful 

litigative prerogatives of the Department 

of Justice. Please contact the 

Department’s Office of Tribal Justice 

(OTJ) with any questions about these 

guidelines and principles. 

Dated: December 3, 2014. 

Eric H. Holder, Jr., 

Attorney General. 

[FR Doc. 2014–28903 Filed 12–11–14; 8:45 am] 

BILLING CODE 4410–A5–P 

DEPARTMENT OF JUSTICE 

Bureau of Alcohol, Tobacco, Firearms, 

and Explosives 

[Docket No. ATF 2014R–50N] 

Granting of Relief; Federal Firearms 

Privileges 

AGENCY: Bureau of Alcohol, Tobacco, 

Firearms and Explosives (ATF), 

Department of Justice. 

ACTION: Notice of granting of restoration 

of Federal firearms privileges. 

SUMMARY: Northrop Grumman Systems 

Corporation (NGSC), a wholly owned 

subsidiary of Northrop Grumman 

Corporation (NGC), has been granted 

relief from the disabilities imposed by 

Federal laws by the Director of ATF 

with respect to the acquisition, receipt, 

transfer, shipment, transportation, or 

possession of firearms. 

FOR FURTHER INFORMATION CONTACT: 

Shermaine Kenner, Enforcement 

Programs and Services; Bureau of 

Alcohol, Tobacco, Firearms and 

Explosives; U.S. Department of Justice; 

99 New York Avenue NE., Washington, 

DC 20226; telephone (202) 648–7070. 

SUPPLEMENTARY INFORMATION: The 

Attorney General is responsible for 

enforcing the provisions of the Gun 

Control Act of 1968 (GCA), 18 U.S.C. 

Chapter 44. He has delegated that 

responsibility to the Director of ATF, 

subject to the direction of the Attorney 

General and the Deputy Attorney 

General. 28 CFR 0.130(a). ATF has 

promulgated regulations that implement 

the provisions of the GCA in 27 CFR 

part 478. 

Section 922(g) of the GCA prohibits 

certain persons from shipping or 

transporting any firearm in interstate or 

foreign commerce, or receiving any 

firearm which has been shipped or 

transported in interstate or foreign 

commerce, or possessing any firearm in 

or affecting commerce. These 

prohibitions apply to any person who— 

(1) Has been convicted in any court of 

a crime punishable by 

imprisonment for a term exceeding 

one year; 

(2) Is a fugitive from justice; 

(3) Is an unlawful user of or addicted to 

any controlled substance; 

(4) Has been adjudicated as a mental 

defective or committed to a mental 

institution; 

(5) Is an alien illegally or unlawfully in 

the United States or, with certain 

exceptions, aliens admitted to the 

United States under a 

nonimmigrant visa; 

(6) Has been discharged from the Armed 

Forces under dishonorable 

conditions; 

(7) Having been a citizen of the United 

States, has renounced U.S. 

citizenship; 

(8) Is subject to a court order that 

restrains the person from harassing, 

stalking, or threatening an intimate 

partner or child of such intimate 

partner; or 

(9) Has been convicted in any court of 

a misdemeanor crime of domestic 

violence. 

The term ‘‘person’’ is defined in 

section 921(a)(1) as including ‘‘any 

individual, corporation, company, 

association, firm, partnership, society, 

or joint stock company.’’ Section 925(c) 

of the GCA provides that a person who 

is prohibited from possessing, shipping, 

transporting, or receiving firearms or 

ammunition may make application to 

the Attorney General to remove the 

firearms disabilities imposed under 

section 922(g) ‘‘if it is established to his 

satisfaction that the circumstances 

regarding the disability, and the 

applicant’s record and reputation, are 

such that the applicant will not be likely 

to act in a manner dangerous to public 

safety and that the granting of the relief 

would not be contrary to the public 

interest.’’ The Attorney General has 

delegated the authority to grant relief 

from firearms disabilities to the Director 

of ATF. 

Section 925(c) further provides that 

‘‘[w]henever the Attorney General grants 

relief to any person pursuant to this 

section he shall promptly publish in the 

Federal Register notice of such action, 

together with the reasons therefor.’’ 

Regulations implementing the 

provisions of section 925(c) are set forth 

in 27 CFR 478.144. 

Since 1992, Congress has eliminated 

funding for ATF to investigate or act 

upon applications for relief from federal 

firearms disabilities submitted by 

individuals. However, since 1993, 

Congress has authorized funding for 

ATF to investigate and act upon 

applications filed by corporations for 

relief from Federal firearms disabilities. 

An application to ATF for relief from 

Federal firearms disabilities under 18 

U.S.C. 925(c) was submitted for NGSC. 

In the matter under review, between 

1993 and 2002, NGSC, a wholly owned 

subsidiary of NGC, merged with and 

succeeded the assets and business 

operations of three non-surviving 

entities that had been convicted in 

Federal court of crimes punishable by 

imprisonment for a term exceeding one 

year. Specifically, TRW Electronic 

Products, Inc. was convicted on 

September 25, 1987, in the United 

States District Court for the District of 

Colorado, Case No. 87 CR–250, for 

violations of 18 U.S.C. 2 and 1001. 

TRW, Inc. was convicted on August 25, 

1988, in the United States District Court 

for the Northern District of Ohio for a 

violation of 18 U.S.C. 371. Litton 

Applied Technology Division was 

convicted on June 30, 1999, in the 

United States District Court for the 

mstockstill on DSK4VPTVN1PROD with NOTICES

Federal Register / Vol. 79, No. 239 / Friday, December 12, 2014 / Notices 73907 

Central District of California, Case No. 

CR 99–673, for a violation of 18 U.S.C. 

371. 

By letter dated June 6, 2012, ATF 

granted relief to Northrop Grumman 

Guidance and Electronics Company, 

Inc., a wholly owned subsidiary of NGC, 

resulting from its own prohibiting 

convictions, but took no action on relief 

to the non-surviving entities because 

they no longer exist. See 77 FR 58150. 

Nonetheless, because NGSC merged 

with and succeeded the assets and 

operations of the non-surviving entities, 

ATF subsequently determined that 

NGSC, as their successor, is eligible for 

relief. 

Pursuant to 18 U.S.C. 925(c), on 

September 23, 2014, NGSC, a wholly 

owned subsidiary of NGC, as successor 

to TRW Electronic Products, Inc., TRW, 

Inc., and Litton Applied Technology 

Division, was granted relief by ATF 

from the disabilities imposed by Federal 

law, 18 U.S.C. 922(g)(1), with respect to 

the acquisition, receipt, transfer, 

shipment, transportation, or possession 

of firearms and ammunition as a result 

of these convictions of the nonsurviving entities. It has been 

established to ATF’s satisfaction that the 

circumstances regarding NGSC’s 

disabilities and its record and 

reputation are such that the NGSC will 

not be likely to act in a manner 

dangerous to public safety, and that the 

granting of the relief would not be 

contrary to the public interest. 

B. Todd Jones, 

Director. 

[FR Doc. 2014–29236 Filed 12–11–14; 8:45 am] 

BILLING CODE 4410–FY–P 

DEPARTMENT OF JUSTICE 

Drug Enforcement Administration 

[Docket No. DEA–405] 

Electronic Prescriptions for Controlled 

Substances: Notice of Approved 

Certification Process 

AGENCY: Drug Enforcement 

Administration, Department of Justice. 

ACTION: Notice of approved certification 

process. 

SUMMARY: The Drug Enforcement 

Administration is announcing one new 

DEA-approved certification process for 

providers of Electronic Prescriptions for 

Controlled Substances applications. 

Certifying organizations with an 

approved certification process are 

posted on the Drug Enforcement 

Administration’s Web site upon 

approval. 

FOR FURTHER INFORMATION CONTACT: 

Imelda L. Paredes, Office of Diversion 

Control, Drug Enforcement 

Administration; Mailing Address: 8701 

Morrissette Drive, Springfield, Virginia 

22152, Telephone: (202) 598–6812. 

SUPPLEMENTARY INFORMATION: 

Legal Authority 

The Drug Enforcement 

Administration (DEA) implements and 

enforces titles II and III of the 

Comprehensive Drug Abuse Prevention 

and Control Act of 1970, as amended. 

Titles II and III are referred to as the 

‘‘Controlled Substances Act’’ and the 

‘‘Controlled Substances Import and 

Export Act,’’ respectively, and are 

collectively referred to as the 

‘‘Controlled Substances Act’’ or the 

‘‘CSA’’ for the purpose of this notice. 21 

U.S.C. 801–971. The DEA publishes the 

implementing regulations for these 

statutes in title 21 of the Code of Federal 

Regulations (CFR), chapter II. The CSA 

and its implementing regulations are 

designed to prevent, detect, and 

eliminate the diversion of controlled 

substances and listed chemicals into the 

illicit market while providing for the 

legitimate medical, scientific, research, 

and industrial needs of the United 

States. Controlled substances have the 

potential for abuse and dependence and 

are controlled to protect the public 

health and safety. 

The CSA and DEA’s implementing 

regulations establish the legal 

requirements for possessing and 

dispensing controlled substances, 

including the issuance of a prescription 

for a legitimate medical purpose by a 

practitioner acting in the usual course of 

professional practice. The responsibility 

for the proper prescribing and 

dispensing of controlled substances is 

upon the prescribing practitioner, but a 

corresponding responsibility rests with 

the pharmacist who fills the 

prescription. 21 CFR 1306.04(a). The 

prescription provides a record of the 

actual dispensing of the controlled 

substance to the ultimate user (the 

patient) and, therefore, is critical to 

documenting that controlled substances 

held by a pharmacy have been 

dispensed. The maintenance of 

complete and accurate records is an 

essential part of the closed system of 

distribution established by Congress. 

Electronic Prescriptions for Controlled 

Substances 

Historically, where Federal law 

required that a prescription for a 

controlled substance be issued in 

writing, that requirement could only be 

satisfied through the issuance of a paper 

prescription. Given advancements in 

technology and security capabilities for 

electronic applications, the DEA 

amended its regulations to provide 

practitioners with the option of issuing 

electronic prescriptions for controlled 

substances in lieu of paper 

prescriptions. The DEA’s interim final 

rule for Electronic Prescriptions for 

Controlled Substances was published on 

March 31, 2010, at 75 FR 16236–16319, 

and became effective on June 1, 2010. 

Update 

Certifying Organization With a 

Certification Process Approved by the 

DEA Pursuant to 21 CFR 1311.300(e) 

The interim final rule and the DEA’s 

Electronic Prescriptions for Controlled 

Substances Clarification (76 FR 64813) 

provide that, as an alternative to the 

third-party audit requirements of 21 

CFR 1311.300(a) through (d), an 

electronic prescription or pharmacy 

application may be verified and 

certified as meeting the requirements of 

21 CFR part 1311 by a certifying 

organization whose certification process 

has been approved by the DEA. The 

preamble to the interim final rule 

further indicated that, once a certifying 

organization’s certification process has 

been approved by the DEA in 

accordance with 21 CFR 1311.300(e), 

such information will be posted on the 

DEA’s Web site. 75 FR 16243 (March 31, 

2010). On December 3, 2014, the DEA 

approved the certification process 

developed by Electronic Healthcare 

Network Accreditation Commission. 

Relevant information has been posted 

on the DEA’s Web site at: http://www.

DEAdiversion.usdoj.gov. 

Dated: December 3, 2014. 

Joseph T. Rannazzisi, 

Deputy Assistant Administrator. 

[FR Doc. 2014–29118 Filed 12–11–14; 8:45 am] 

BILLING CODE 4410–09–P 

NUCLEAR REGULATORY 

COMMISSION 

[Docket No. 72–0008, NRC–2011–0085] 

Exelon Generation Corporation, LLC; 

Calvert Cliffs Independent Spent Fuel 

Storage Installation 

AGENCY: Nuclear Regulatory 

Commission. 

ACTION: License amendment application; 

notice of docketing; opportunity to 

request a hearing and to petition for 

leave to intervene; and order. 

SUMMARY: The U.S. Nuclear Regulatory 

Commission (NRC) has docketed a 

license amendment application from 

mstockstill on DSK4VPTVN1PROD with NOTICES